Pediatric Blood Transfusion
Pediatric blood transfusion is the process of administering blood products to children to correct anemia, replace blood loss, or improve oxygen-carrying capacity. Unlike adults, where transfusion volumes are typically given as whole units, pediatric transfusions must be precisely calculated based on the child's weight to avoid volume overload while achieving the desired hemoglobin increment.
The decision to transfuse depends on multiple factors beyond hemoglobin level alone, including the rate of blood loss, clinical symptoms, cardiovascular stability, underlying diagnoses, and the ability of the patient to compensate. A hemoglobin-based transfusion trigger is a guide, not an absolute threshold.
In pediatrics, the estimated blood volume varies with age: approximately 80 mL/kg in neonates, 75–80 mL/kg in infants, and 70 mL/kg in older children and adolescents. This blood volume factor is critical for accurate transfusion volume calculations.
Transfusion Volume Formula
The most commonly used formula for calculating pRBC transfusion volume in children:
Simplified version using a factor of 3 (assumes blood volume ~70–80 mL/kg and Hct conversion):
Rule of thumb: 10–15 mL/kg of pRBC will raise hemoglobin by approximately 2–3 g/dL in a child.
| Age Group | Estimated Blood Volume | Factor Used |
|---|---|---|
| Premature neonate | 90–100 mL/kg | ~3.3 |
| Term neonate (0–28 days) | 80–85 mL/kg | ~3.0 |
| Infant (1–12 months) | 75–80 mL/kg | ~2.8 |
| Child (1–12 years) | 70–75 mL/kg | ~2.5 |
| Adolescent (>12 years) | 65–70 mL/kg | ~2.3 |
Transfusion Triggers
Transfusion triggers vary based on clinical context. The following are general guidelines from major pediatric hematology organizations:
| Clinical Context | Transfusion Trigger (Hgb g/dL) | Notes |
|---|---|---|
| Stable, non-bleeding child | < 7.0 | Restrictive threshold preferred; well-tolerated in most cases |
| PICU / critically ill | < 7.0 | TRIPICU study supports restrictive strategy (7 g/dL threshold) |
| Cyanotic heart disease | < 9.0–10.0 | Higher threshold due to oxygen delivery requirements |
| Sickle cell disease (chronic) | < 6.0–7.0 | Or for pre-operative preparation; exchange transfusion may be preferred |
| Active hemorrhage | Clinical decision | Based on rate of bleeding and hemodynamic stability, not Hgb alone |
| Neonates (first week) | Variable (10–13) | Depends on gestational age, respiratory support, and clinical condition |
Transfusion Decision Diagram
Blood Product Types
Different blood products are available for pediatric transfusion, each with specific indications:
| Product | Hematocrit | Volume per Unit | Indications |
|---|---|---|---|
| Packed Red Blood Cells (pRBC) | 55–65% | ~250–300 mL | Anemia, blood loss; most commonly used product |
| Whole Blood | 35–40% | ~450 mL | Massive hemorrhage, exchange transfusion in neonates |
| Washed pRBC | ~70–80% | ~200 mL | Patients with IgA deficiency or severe allergic reactions |
| Irradiated pRBC | 55–65% | ~250–300 mL | Immunocompromised patients, directed donations, neonates |
| Leukoreduced pRBC | 55–65% | ~250–300 mL | CMV risk reduction, febrile reactions; standard in many centers |
Safety and Complications
Pediatric blood transfusion carries risks that must be weighed against benefits:
- Transfusion-associated circulatory overload (TACO): Volume overload is a significant risk in small children. Infuse pRBC at 5–10 mL/kg/hour (max 15 mL/kg/hour in stable patients). Consider furosemide (1 mg/kg IV) for patients with cardiac compromise.
- Febrile non-hemolytic transfusion reaction (FNHTR): Most common reaction. Presents with fever, chills, and rigors. Treated with antipyretics; prevented by leukoreduction.
- Allergic reactions: Range from mild urticaria (treated with diphenhydramine) to anaphylaxis (rare, requires epinephrine). Washed products reduce risk.
- Acute hemolytic reaction: Medical emergency caused by ABO incompatibility. Presents with fever, back pain, hemoglobinuria, and hypotension. Stop transfusion immediately and provide supportive care.
- Transfusion-associated graft-versus-host disease (TA-GVHD): Rare but often fatal. Prevented by irradiation of blood products for at-risk patients.
- Iron overload: A concern in chronically transfused patients (thalassemia, sickle cell disease). Each unit of pRBC contains approximately 200–250 mg of iron. Iron chelation therapy is initiated when ferritin exceeds 1,000 ng/mL or after approximately 10–20 transfusions.
Worked Example
A 10 kg child with hemoglobin of 6.5 g/dL. Target hemoglobin is 10 g/dL. Using pRBC with hematocrit of 60%:
This is 17.5 mL/kg. At a standard infusion rate of 5 mL/kg/hr, the transfusion would take approximately 3.5 hours.
Rule of thumb check: 10–15 mL/kg raises Hgb by ~2–3 g/dL. At 17.5 mL/kg, the expected rise of 3.5 g/dL is consistent with the formula calculation.
Frequently Asked Questions
What infusion rate should be used for pediatric transfusions?
Standard infusion rate is 5–10 mL/kg/hour for hemodynamically stable children. Start slowly (1–2 mL/kg/hour for the first 15 minutes) to monitor for reactions. Maximum rate in non-emergent situations is 15 mL/kg/hour. In active hemorrhage or hemodynamic instability, blood can be given as a bolus (10–20 mL/kg over 5–10 minutes).
How soon should hemoglobin be rechecked after transfusion?
Post-transfusion hemoglobin should be checked 1–4 hours after completion of the transfusion to allow equilibration. Immediate post-transfusion levels may not accurately reflect the true hemoglobin rise due to hemodilution from IV fluids or ongoing losses.
Can all pediatric patients receive any blood type?
No. Pediatric patients must receive ABO-compatible and Rh-compatible blood. Neonates under 4 months of age may have maternal antibodies, so cross-matching must consider both the infant's and mother's blood type. Type O Rh-negative pRBC is the universal donor type used in emergencies when the patient's type is unknown.
What is the maximum storage time for pediatric transfusion units?
pRBCs can be stored for up to 42 days (with CPDA-1 or additive solution). For neonates and small infants, many centers prefer "fresh" blood (less than 7–14 days old) due to concerns about potassium and 2,3-DPG levels in older units, though evidence for clinical benefit is limited. Assigned aliquots from a single donor unit reduce donor exposure in neonates requiring multiple small transfusions.